Impax Asset Management Group plc Acquires 194,252 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Impax Asset Management Group plc increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3,759.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 199,419 shares of the medical equipment provider's stock after acquiring an additional 194,252 shares during the period. Impax Asset Management Group plc owned approximately 0.06% of Intuitive Surgical worth $103,768,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter worth about $26,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. Sierra Ocean LLC bought a new position in Intuitive Surgical during the fourth quarter worth $40,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter worth $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ISRG shares. UBS Group boosted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Truist Financial upped their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Finally, Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm's stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,240 shares of company stock worth $3,529,040. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $11.80 on Wednesday, hitting $585.54. 474,222 shares of the stock were exchanged, compared to its average volume of 1,704,119. The company has a market capitalization of $208.56 billion, a price-to-earnings ratio of 91.32, a P/E/G ratio of 5.85 and a beta of 1.39. The company's 50-day moving average price is $567.01 and its two-hundred day moving average price is $527.27. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.